Jia Jie Biomedical Co (ROCO:4109) Beginning Cash Position: NT$253.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4109 Jia Jie Biomedical Co Ltd ROCO:4109
59 GF Score
Price NT$11.00
GF Value NT$16.02
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jia Jie Biomedical Co Beginning Cash Position?

Jia Jie Biomedical Co ROCO:4109 -0.45% 59 Beginning Cash Position is NT$253.6 Mil as of Jun. 2026. GuruFocus rates ROCO:4109 with a GF Score™ of 59/100 and a GF Value™ of NT$16.02 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Jia Jie Biomedical Co's Beginning Cash Position for the quarter that ended in Jun. 2026 was NT$253.6 Mil.

Jia Jie Biomedical Co's quarterly Beginning Cash Position declined from Dec. 2025 (NT$309.9 Mil) to Mar. 2026 (NT$296.5 Mil) and declined from Mar. 2026 (NT$296.5 Mil) to Jun. 2026 (NT$253.6 Mil).

Jia Jie Biomedical Co's annual Beginning Cash Position increased from Dec. 2023 (NT$125.5 Mil) to Dec. 2024 (NT$354.4 Mil) but then declined from Dec. 2024 (NT$354.4 Mil) to Dec. 2025 (NT$112.9 Mil).

Jia Jie Biomedical Co Beginning Cash Position Related Terms

Jia Jie Biomedical Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Jia Jie Biomedical Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jia Jie Biomedical Co Beginning Cash Position Chart

Jia Jie Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 344.16 172.28 125.53 354.42 112.94

Jia Jie Biomedical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.32 319.09 309.94 296.47 253.59
ROCO:4109
59GF Score
Jia Jie Biomedical Co Ltd ROCO:4109
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jia Jie Biomedical Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NT$253.6 Mil mean?
Jia Jie Biomedical Co (ROCO:4109) has a Beginning Cash Position of NT$253.6 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Jia Jie Biomedical Co and its competitors.
Is Jia Jie Biomedical Co's Beginning Cash Position too high?
Jia Jie Biomedical Co's current Beginning Cash Position is NT$253.6 Mil. Overall, Jia Jie Biomedical Co has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jia Jie Biomedical Co's Beginning Cash Position compare to KHC and GIS?
Jia Jie Biomedical Co's Beginning Cash Position of NT$253.6 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Consumer Packaged Goods company?
A good Beginning Cash Position depends on the Consumer Packaged Goods industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Jia Jie Biomedical Co and its competitors. Jia Jie Biomedical Co's current Beginning Cash Position is NT$253.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jia Jie Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Jia Jie Biomedical Co (ROCO:4109) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$16.02, compared to a current price of NT$11.00 — trading 31.3% below its estimated fair value. The current Beginning Cash Position is NT$253.6 Mil. Jia Jie Biomedical Co's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Jia Jie Biomedical Co (ROCO:4109), the current Beginning Cash Position is NT$253.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jia Jie Biomedical Co (ROCO:4109) Overvalued in 2026?

Based on GuruFocus' analysis, Jia Jie Biomedical Co stock appears to be undervalued. The current stock price of NT$11.00 is trading 31.3% below its estimated GF Value™ of NT$16.02. GuruFocus considers Jia Jie Biomedical Co to be Significantly Undervalued.

Key valuation signals for ROCO:4109:

  • Beginning Cash Position: NT$253.6 Mil
  • GF Value™: NT$16.02 vs. price of NT$11.00 (31.3% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4109 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jia Jie Biomedical Co Business Description

Address Jiuru 1st Road, 3rd Floor, No. 61, Sanmin District, Kaohsiung City, TWN, 807
Jia Jie Biomedical Co Ltd is a Taiwan-based company. The Company is engaged in the processing, sale, and trading of softshell turtle food, the Manufacture of Dairy Products, and miscellaneous food manufacturing (e.g., softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules). The company is also engaged in the import, export of the aforementioned products, the distribution, bidding, and quotation of aforementioned products for domestic and foreign manufacturers, Wholesale of Nonalcoholic Beverages, candy wholesale, baked food wholesale, supplementary food wholesale, cosmetics wholesale, and sports equipment wholesale.
59GF Score

Get the complete analysis for ROCO:4109

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$11.00
Price
NT$16.02
GF Value